Oruka Therapeutics
Price & Volume
Stats
See moreOpen | $16.70 |
Previous Close | $15.20 |
Day Range | $15.97-$19.97 |
52W Range | $5.49-$31.13 |
Market Cap | $735.4M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0 |
News
See moreYahoo Finance • 13 days ago
Oruka Therapeutics, Up 9%, Is Trying To Take On AbbVie's Biggest Moneymaker
Yahoo Finance • 13 days ago
Oruka jumps as lead drug outperforms AbbVie’s Skyrizi in early-stage trial
Yahoo Finance • 13 days ago
Oruka Therapeutics Reports Positive Interim Data From Phase 1 Study Of ORKA-001
Yahoo Finance • 13 days ago
Oruka Therapeutics Announces $180 Million Private Placement
About
CEO | Dr. Lawrence Otto Klein Ph.D. |
Address | 855 Oak Grove Avenue, Menlo Park, CA, United States, 94025 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 28 |
